Antidiabetic and hypolipidemic activities of Sanghuangporus vaninii compounds in streptozotocin‐induced diabetic mice via modulation of intestinal microbiota

Ähnliche Einträge

• Punicalagin prevents the bone loss of diabetic mice induced by high‐fat diet via the metabolism of gut microbiota
  von: Jie Gao, et al.
  Veröffentlicht: (2024)
• A novel arabinogalactan extracted from Epiphyllum oxypetalum (DC.) Haw improves the immunity and gut microbiota in cyclophosphamide‐induced immunosuppressed mice
  von: Jin Dai, et al.
  Veröffentlicht: (2024)
• Research on the effects of intestinal FXR agonists and antibiotics on the regulation of red kidney bean polysaccharides in the liver metabolism in mice with type 2 diabetes
  von: Yunhui Zhang, et al.
  Veröffentlicht: (2024)
• Inulin alleviates acute alcoholism in mice by enhancing ethanol metabolism and regulating the intestinal flora
  von: Zhouya Bai, et al.
  Veröffentlicht: (2024)
• Exploring the therapeutic potential of Bifidobacterium longum subsp. longum CCFM1029 in Parkinson's disease: Insights from behavioral, neurophysiological, gut microbiota, and microbial metabolites analysis
  von: Tiantian Li, et al.
  Veröffentlicht: (2024)